Benfotiamine and Long-Chain Omega-3 and Omega-6 Polyunsaturated Fatty Acids in Treatment of Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
Introduction. The cardiovascular form of diabetic autonomic neuropathy (DANP) in patients with type 2 diabetes mellitus (DM), is characterized by the damage of the nerve fibers of the parasympathetic and sympathetic parts of the autonomic nervous system, and is considered to be one of the main cause...
Saved in:
| Main Authors: | Serhiyenko V., Serhiyenko O. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House "Kyrylytsya"
2013-09-01
|
| Series: | Львівський клінічний вісник |
| Subjects: | |
| Online Access: | http://lkv.biz/benfotiamine-and-long-chain-omega-3-and-omega-6-polyunsaturated-fatty-acids-in-treatment-of-cardiac-autonomic-neuropathy-in-patients-with-type-2-diabetes-mellitus/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Content of Some Pro- and Anti-inflammatory Factors, Insulin Resistance Parameters in Patients with Type 2 Diabetes Mellitus and Cardiovascular Autonomic Neuropathy, Influence of Omega-3 Polyunsaturated Fatty Acids on These Parameters
by: Serhiyenko V., et al.
Published: (2017-09-01) -
Features of Lipid Spectrum and Insulin Resistance Parameters in Patients with Type 2 Diabetes Mellitus and Cardiac Autonomic Neuropathy and Appropriateness of Simvastatin and Omega-3 Polyunsaturated Fatty Acids Combined Prescription
by: Azhmi S., et al.
Published: (2017-09-01) -
The effect of OMEGA-3 polyunsaturated fatty acids on ambulatory blood pressure monitoring parameters in patients with type 2 diabetes mellitus and cardiovascular autonomic neuropathy
by: Victoria A. Serhiyenko, et al.
Published: (2019-03-01) -
OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES
by: A. V. Govorin, et al.
Published: (2015-12-01) -
Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: V. A. Serhiyenko, et al.
Published: (2019-05-01)